CONNECT_MM: For patients with newly diagnosed multiple myeloma

Study Information

Study Title

CONNECT MM Registry for Relapsed/Refractory MM (COHORT 3)

Study Summary

The purpose of this clinical trial is to evaluate the effectiveness of second line treatment regimens and subsequent therapeutic strategies and understand impact of changes in the second line treatment landscape and associated clinical outcomes over time.

Disease State

Multiple Myeloma on 2nd Line of Treatment

Principal Investigator

Waqas Rehman, MD

Phase Observational

If you have any questions regarding this study or think that you or your loved one may be eligible, please contact our Clinical Trial Coordinator by dialing 908.237.1201 extension 262.

Contact HHO

All questions and feedback are welcome, anytime.

    About HHO

    Hunterdon Hematology Oncology is a community oncology group, dedicated to fighting cancer in this community and across the region. Our Doctors, Physician’s Assistants and Nurses work tirelessly. They fight hard so that you can win.


    Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.

      © HHO 2022. All rights reserved. Designed by DRAW